| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -11% |
| 3Y CAGR | -1% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +14% |
| 3Y CAGR | +1% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,527.90 +25.40 (1.01%) | 19,010.91 | 28.04 | 5.64 | ||
PfizerPFIZER | ₹3,926.10 +8.20 (0.21%) | 17,930.59 | 20.86 | 4.09 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,522.00 +7.50 (0.12%) | 16,280.50 | 91.61 | 18.52 | ||
Natco PharmaNATCOPHARM | ₹811.00 +6.65 (0.83%) | 15,772.88 | 13.78 | 1.5 |